$MXL
MAXLINEAR, INC Stock $mxl

$mxl Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000128846924000112 Filed on July 24, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$81.10M	$91.99M
YoY Change	-40.16%	-49.99%
Cost Of Revenue	$37.02M	$41.80M
YoY Change	-39.89%	-48.43%
Gross Profit	$44.08M	$50.19M
YoY Change	-40.39%	-51.22%
Gross Profit Margin	54.35%	54.56%
Selling, General & Admin	$30.15M	$33.60M
YoY Change	18.71%	1.79%
% of Gross Profit	68.41%	66.95%
Research & Development	$52.60M	$56.54M
YoY Change	-20.66%	-19.98%
% of Gross Profit	119.34%	112.66%
Depreciation & Amortization	$5.800M	$5.700M
YoY Change	3.57%	-69.53%
% of Gross Profit	13.16%	11.36%
Operating Expenses	$110.8M	$91.01M
YoY Change	20.77%	-12.81%
Operating Profit	-$66.74M	-$40.82M
YoY Change	274.58%	2619.52%
Interest Expense	-$1.002M	-$835.0K
YoY Change	-136.91%	-43.88%
% of Operating Profit
Other Income/Expense, Net	-$15.76M	-$506.0K
YoY Change	-33.52%	-118.99%
Pretax Income	-$82.50M	-$41.33M
YoY Change	98.7%	768.19%
Income Tax	-$6.700M	-$2.100M
% Of Pretax Income
Net Earnings	-$75.79M	-$39.27M
YoY Change	90.28%	802.46%
Net Earnings / Revenue	-93.44%	-42.69%
Basic Earnings Per Share	-$0.90	-$0.47
Diluted Earnings Per Share	-$0.90	-$0.47
COMMON SHARES
Basic Shares Outstanding	83.90M shares	83.13M shares
Diluted Shares Outstanding	84.07M shares	83.48M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$148.5M	$185.1M
YoY Change	-26.37%	-24.47%
Cash & Equivalents	$148.5M	$185.1M
Short-Term Investments
Other Short-Term Assets	$35.79M	$32.80M
YoY Change	5.91%	19.52%
Inventory	$96.06M	$94.74M
Prepaid Expenses
Receivables	$47.93M	$84.94M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$328.3M	$397.6M
YoY Change	-35.46%	-28.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$63.49M	$65.42M
YoY Change	-8.62%	-39.96%
Goodwill	$318.6M	$318.6M
YoY Change	0.04%	0.04%
Intangibles	$58.03M	$61.79M
YoY Change	-29.78%	-32.25%
Long-Term Investments
YoY Change
Other Assets	$21.81M	$30.69M
YoY Change	-33.54%	-65.28%
Total Long-Term Assets	$567.0M	$575.6M
YoY Change	-4.73%	-5.17%
TOTAL ASSETS
Total Short-Term Assets	$328.3M	$397.6M
Total Long-Term Assets	$567.0M	$575.6M
Total Assets	$895.3M	$973.2M
YoY Change	-18.89%	-16.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$30.63M	$35.63M
YoY Change	-32.24%	-22.37%
Accrued Expenses	$71.20M	$70.97M
YoY Change	-17.48%	-61.92%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$168.6M	$190.3M
YoY Change	-27.61%	-21.28%
LONG-TERM LIABILITIES
Long-Term Debt	$122.8M	$122.7M
YoY Change	0.51%	0.51%
Other Long-Term Liabilities	$27.56M	$21.46M
YoY Change	53.42%	-58.45%
Total Long-Term Liabilities	$150.4M	$144.1M
YoY Change	7.29%	-17.02%
TOTAL LIABILITIES
Total Short-Term Liabilities	$168.6M	$190.3M
Total Long-Term Liabilities	$150.4M	$144.1M
Total Liabilities	$338.4M	$355.9M
YoY Change	-15.63%	-14.32%
SHAREHOLDERS EQUITY
Retained Earnings	-$305.9M	-$230.1M
YoY Change	282.23%	472.42%
Common Stock	$866.6M	$853.9M
YoY Change	9.61%	8.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$556.9M	$617.3M
YoY Change
Total Liabilities & Shareholders Equity	$895.3M	$973.2M
YoY Change	-18.89%	-16.21%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$75.79M	-$39.27M
YoY Change	90.28%	802.46%
Depreciation, Depletion And Amortization	$5.800M	$5.700M
YoY Change	3.57%	-69.53%
Cash From Operating Activities	-$30.73M	-$2.696M
YoY Change	140.24%	-108.82%
INVESTING ACTIVITIES
Capital Expenditures	$5.950M	$5.788M
YoY Change	128.76%	-54.25%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$5.950M	-$5.788M
YoY Change	128.76%	-54.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-58.00K	2.026M
YoY Change	-99.73%	1775.93%
NET CHANGE
Cash From Operating Activities	-30.73M	-2.696M
Cash From Investing Activities	-5.950M	-5.788M
Cash From Financing Activities	-58.00K	2.026M
Net Change In Cash	-36.74M	-6.458M
YoY Change	-0.32%	-135.81%
FREE CASH FLOW
Cash From Operating Activities	-$30.73M	-$2.696M
Capital Expenditures	$5.950M	$5.788M
Free Cash Flow	-$36.68M	-$8.484M
YoY Change	138.3%	-147.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81818000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81818000	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	676385000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2438000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	31926000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16460000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-192000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	9533000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	734112000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-111575000	usd
	mxl	Amortization Of Debt Issuance Cost And Accretion Of Discounts AmortizationOfDebtIssuanceCostAndAccretionOfDiscounts	1173000	usd
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-40209000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5429000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-114300000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3912000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	686265000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8777000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17032000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1782000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-72309000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	637983000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-545000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2682000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17344000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-943000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-39266000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	617255000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-2752000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2989000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17127000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1078000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4351000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	746047000	usd
	us-gaap	Net Income Loss NetIncomeLoss	5182000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	30284000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	37909000	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2438000	usd
	mxl	Amortization Of Debt Issuance Cost And Accretion Of Discounts AmortizationOfDebtIssuanceCostAndAccretionOfDiscounts	1353000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	34420000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	33645000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4738000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	8886000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-445000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-2041000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1959000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	2738000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
	mxl	Gain Loss On Extinguishment Of Lease Liabilities GainLossOnExtinguishmentOfLeaseLiabilities	553000	usd
	mxl	Gain Loss On Extinguishment Of Lease Liabilities GainLossOnExtinguishmentOfLeaseLiabilities	0	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1366000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-153000	usd
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1519000	usd
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1298000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-85679000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-16167000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-5170000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-34392000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	763000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5652000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-12271000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-27264000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2852000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	3862000	usd
	mxl	Increase Decreasein Accrued Price Protection Liability IncreaseDecreaseinAccruedPriceProtectionLiability	-10054000	usd
	mxl	Increase Decreasein Accrued Price Protection Liability IncreaseDecreaseinAccruedPriceProtectionLiability	-33041000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5045000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-6009000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1783000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	2112000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13274000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	72737000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11355000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10253000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3143000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	5524000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	12384000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14498000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28161000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1579000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3076000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1656000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	9138000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-77000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6062000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-918000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1228000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2219000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	37286000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	188356000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	188357000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	186137000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	225643000	usd
	us-gaap	Interest Paid Net InterestPaidNet	4952000	usd
	us-gaap	Interest Paid Net InterestPaidNet	4503000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	3421000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	14784000	usd
	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	10992000	usd
	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	38225000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates and Significant Risks and Uncertainties</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes of the consolidated financial statements. Actual results could differ from those estimates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not aware of any specific event or circumstance that would require an update to its estimates or adjustments to the carrying value of its assets and liabilities as of July 24, 2024, the issuance date of this Quarterly Report on Form 10-Q. Actual results could differ from those estimates.</span></div>
	mxl	Contract With Customer Payment Term ContractWithCustomerPaymentTerm	P30D
	mxl	Contract With Customer Stock Rotation Allowance Term ContractWithCustomerStockRotationAllowanceTerm	P6M
	mxl	Revenue Performance Obligation Delivery Term RevenuePerformanceObligationDeliveryTerm	P1Y
	mxl	Sales Commission Assets Recognized Term SalesCommissionAssetsRecognizedTerm	P1Y
	mxl	Contract With Customer Right Of Return Term ContractWithCustomerRightOfReturnTerm	P6M
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	mxl	Number Of Business Activities NumberOfBusinessActivities	1	business_activity
CY2024Q2	us-gaap	Research And Development Arrangement Contract To Perform For Others Compensation Earned ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned	1500000	usd
CY2023Q2	us-gaap	Research And Development Arrangement Contract To Perform For Others Compensation Earned ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned	1000000.0	usd
	us-gaap	Research And Development Arrangement Contract To Perform For Others Compensation Earned ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned	2400000	usd
	us-gaap	Research And Development Arrangement Contract To Perform For Others Compensation Earned ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned	9900000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P12M
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-39266000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4351000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-111575000	usd
	us-gaap	Net Income Loss NetIncomeLoss	5182000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	83477000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80446000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82913000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79961000	shares
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1559000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	83477000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80446000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82913000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81520000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.35
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.35
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6000000.0	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5400000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6300000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3200000	shares
CY2024Q2	us-gaap	Restructuring Charges RestructuringCharges	865000	usd
CY2023Q2	us-gaap	Restructuring Charges RestructuringCharges	4436000	usd
	us-gaap	Restructuring Charges RestructuringCharges	23495000	usd
	us-gaap	Restructuring Charges RestructuringCharges	9084000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	8301000	usd
	us-gaap	Restructuring Charges RestructuringCharges	23495000	usd
	us-gaap	Payments For Restructuring PaymentsForRestructuring	17684000	usd
	mxl	Restructuring Reserve Non Cash Charges And Adjustments RestructuringReserveNonCashChargesAndAdjustments	-3289000	usd
CY2024Q2	us-gaap	Restructuring Reserve RestructuringReserve	10823000	usd
CY2024Q2	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	10823000	usd
CY2024Q2	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	0	usd
CY2023Q4	us-gaap	Goodwill Goodwill	318588000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	306739000	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	11717000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	318588000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	318456000	usd
CY2023Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q2	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P6Y1M6D
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	482917000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	421131000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	61786000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	479774000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	406144000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	73630000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5928000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10043000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14987000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20430000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	73630000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	109316000	usd
	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	3143000	usd
	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	5524000	usd
	mxl	Finite Lived Intangible Assets Disposals FiniteLivedIntangibleAssetsDisposals	0	usd
	mxl	Finite Lived Intangible Assets Disposals FiniteLivedIntangibleAssetsDisposals	769000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14987000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20430000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	61786000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	91203000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2400000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	8370000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	14795000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	13966000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	10354000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5016000	usd
CY2024Q2	mxl	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	9285000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	61786000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2600000	usd
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	11800000	usd
CY2024Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	11800000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	185108000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	187288000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1006000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1051000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	23000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	17000	usd
CY2024Q2	mxl	Cashcashequivalentsandrestrictedcash Cashcashequivalentsandrestrictedcash	186137000	usd
CY2023Q4	mxl	Cashcashequivalentsandrestrictedcash Cashcashequivalentsandrestrictedcash	188356000	usd
CY2024Q2	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	112400000	usd
CY2023Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	78100000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1000000.0	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1100000	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	58455000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	60368000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	36283000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	39540000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	94738000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	99908000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	190768000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	182609000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	125346000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	116178000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	65422000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	66431000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	5700000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	6500000	usd
	us-gaap	Depreciation Depreciation	11200000	usd
	us-gaap	Depreciation Depreciation	12900000	usd
CY2022Q1	mxl	Proceeds Loaned Under Notes Receivable ProceedsLoanedUnderNotesReceivable	10000000	usd
CY2023Q3	mxl	First Initial Repayments Of Notes Receivable Due To The Company Annually FirstInitialRepaymentsOfNotesReceivableDueToTheCompanyAnnually	1500000	usd
CY2023Q3	mxl	Repayments Of Notes Receivable Due To The Company Annually RepaymentsOfNotesReceivableDueToTheCompanyAnnually	1700000	usd
CY2024Q2	mxl	Proceeds Loaned Under Notes Receivable Current ProceedsLoanedUnderNotesReceivableCurrent	1500000	usd
CY2023Q3	mxl	Repayments Of Notes Receivable Due To The Company Annually RepaymentsOfNotesReceivableDueToTheCompanyAnnually	2000000	usd
CY2023Q4	mxl	Accrued Price Protection Liability AccruedPriceProtectionLiability	71684000	usd
CY2022Q4	mxl	Accrued Price Protection Liability AccruedPriceProtectionLiability	113274000	usd
	mxl	Price Protection Rebate Charges PriceProtectionRebateCharges	23266000	usd
	mxl	Price Protection Rebate Charges PriceProtectionRebateCharges	37726000	usd
	mxl	Price Protectionpayments PriceProtectionpayments	33320000	usd
	mxl	Price Protectionpayments PriceProtectionpayments	70867000	usd
CY2024Q2	mxl	Accrued Price Protection Liability AccruedPriceProtectionLiability	61630000	usd
CY2023Q2	mxl	Accrued Price Protection Liability AccruedPriceProtectionLiability	80133000	usd
CY2023Q4	mxl	Accrued Price Protection Liability AccruedPriceProtectionLiability	71700000	usd
CY2024Q2	mxl	Accrued Price Protection Liability AccruedPriceProtectionLiability	61600000	usd
CY2024Q2	mxl	Accrued Technology License Payments Current AccruedTechnologyLicensePaymentsCurrent	3627000	usd
CY2023Q4	mxl	Accrued Technology License Payments Current AccruedTechnologyLicensePaymentsCurrent	3843000	usd
CY2024Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4173000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3736000	usd
CY2024Q2	mxl	Accrued Engineering And Production Costs AccruedEngineeringAndProductionCosts	6767000	usd
CY2023Q4	mxl	Accrued Engineering And Production Costs AccruedEngineeringAndProductionCosts	2861000	usd
CY2024Q2	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	10823000	usd
CY2023Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	8301000	usd
CY2024Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	400000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	603000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9625000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9132000	usd
CY2024Q2	mxl	Accrued Customer Credits AccruedCustomerCredits	3711000	usd
CY2023Q4	mxl	Accrued Customer Credits AccruedCustomerCredits	3984000	usd
CY2024Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	392000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	521000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2614000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1597000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2600000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2462000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5571000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6242000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	70965000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	98468000	usd
	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-2725000	usd
CY2024Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.079
CY2023Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.076
CY2024Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	200000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	200000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	300000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	300000	usd
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	125000000.0	usd
CY2024Q2	mxl	Aggregate Commitments Percentage AggregateCommitmentsPercentage	0.01
CY2024Q1	mxl	Shares Issued Upon Settlement Of Executive Bonus Plan SharesIssuedUponSettlementOfExecutiveBonusPlan	400000	shares
CY2024Q2	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	4800000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17359000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17197000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	34420000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	33645000	usd
	mxl	Vesting Percentage Relative To Net Sales VestingPercentageRelativeToNetSales	0.60
	mxl	Vesting Percentage Relative To Eps VestingPercentageRelativeToEPS	0.40
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	375000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.29
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2688000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	19.45
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	39000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	7.68
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	1000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	23.75
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3023000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	19.33
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y8M12D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5884000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	2785000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	19.32
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y7M13D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	5447000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	335000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	18.40
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y1M9D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	965000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	500000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	200000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	0	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	100000	usd
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	800000	usd
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	300000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2100000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-400000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3800000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15200000	usd
	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-300000	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	100000	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	4000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	91990000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	183938000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	187259000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	432380000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2600000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1600000	usd
CY2024Q2	mxl	Accrued Price Protection Liability AccruedPriceProtectionLiability	61600000	usd
CY2023Q4	mxl	Accrued Price Protection Liability AccruedPriceProtectionLiability	71700000	usd
CY2024Q2	us-gaap	Contract With Customer Right To Recover Product ContractWithCustomerRightToRecoverProduct	45000	usd
CY2023Q4	us-gaap	Contract With Customer Right To Recover Product ContractWithCustomerRightToRecoverProduct	100000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.047
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.046
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y7M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y10M24D
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	5501000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	10647000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	8293000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5952000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2455000	usd
CY2024Q2	mxl	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	1596000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	34444000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3297000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	31147000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9625000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	21522000	usd
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	2500000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	2500000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	5100000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	5400000	usd
CY2024Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	300000	usd
CY2023Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	12000000.0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1200000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	12200000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Amounts Recognized In Balance Sheet DefinedBenefitPlanAmountsRecognizedInBalanceSheet	400000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Amounts Recognized In Balance Sheet DefinedBenefitPlanAmountsRecognizedInBalanceSheet	1400000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	48000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	100000	usd
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	200000	usd
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	100000	usd
CY2024Q2	us-gaap	Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear	36332000	usd
CY2024Q2	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	43999000	usd
CY2024Q2	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	18972000	usd
CY2024Q2	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	3673000	usd
CY2024Q2	us-gaap	Contractual Obligation ContractualObligation	102976000	usd
CY2024Q2	mxl	Research And Development Arrangement Contract For A Jointly Funded Project Cumulative Proceeds Received From Other Party Deferred In Liabilities ResearchAndDevelopmentArrangementContractForAJointlyFundedProjectCumulativeProceedsReceivedFromOtherPartyDeferredInLiabilities	15000000	usd
CY2021Q1	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000	usd
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	55000000.0	usd
CY2024Q1	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	0	shares
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001288469-24-000112-index-headers.html	Edgar Link	pending
0001288469-24-000112-index.html	Edgar Link	pending
0001288469-24-000112.txt	Edgar Link	pending
0001288469-24-000112-xbrl.zip	Edgar Link	pending
a6302024exhibit311.htm	Edgar Link	pending
a6302024exhibit312.htm	Edgar Link	pending
a6302024exhibit321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mxl-20240630.htm	Edgar Link	pending
mxl-20240630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
mxl-20240630_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
mxl-20240630_def.xml	Edgar Link	unprocessable
mxl-20240630_lab.xml	Edgar Link	unprocessable
mxl-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
mxl-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MXL
MAXLINEAR, INC Stock $mxl

2024 Q3 Form 10-Q Financial Statement

#000128846924000112 Filed on July 24, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MXL MAXLINEAR, INC Stock $mxl

2024 Q3 Form 10-Q Financial Statement

#000128846924000112 Filed on July 24, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MXL
MAXLINEAR, INC Stock $mxl